The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
5 01 ACQUISITION CORP | COM CL A | 33836P105 | 1,964 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
AC IMMUNE SA | SHS | H00263105 | 5,041 | 751,251 | SH | SOLE | 751,251 | 0 | 0 | ||
AKOUOS INC | COM | 00973J101 | 22,941 | 1,975,984 | SH | SOLE | 1,975,984 | 0 | 0 | ||
ALECTOR INC | COM | 014442107 | 113,985 | 4,994,970 | SH | SOLE | 4,994,970 | 0 | 0 | ||
ALPINE IMMUNE SCIENCES INC | COM | 02083G100 | 75 | 7,001 | SH | SOLE | 7,001 | 0 | 0 | ||
ANAPTYSBIO INC | COM | 032724106 | 203,970 | 7,521,024 | SH | SOLE | 7,521,024 | 0 | 0 | ||
ARCUS BIOSCIENCES INC | COM | 03969F109 | 178,617 | 5,122,359 | SH | SOLE | 5,122,359 | 0 | 0 | ||
ARYA SCIENCES ACQU CORP IV | CL A | G31659108 | 1,508 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 67,967 | 2,759,505 | SH | SOLE | 2,759,505 | 0 | 0 | ||
BCLS ACQUISITION CORP | COM CL A | G0904B105 | 1,992 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
BIOATLA INC | COM | 09077B104 | 1,472 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
BLUEBIRD BIO INC | COM | 09609G100 | 15,336 | 802,507 | SH | SOLE | 802,507 | 0 | 0 | ||
BLUEPRINT MEDICINES CORP | COM | 09627Y109 | 25,933 | 250,000 | SH | Call | SOLE | 250,000 | 0 | 0 | |
BOLT BIOTHERAPEUTICS INC | COM | 097702104 | 1,848 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
C4 THERAPEUTICS INC | COM STK | 12529R107 | 8,936 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
CAREMAX INC | *W EXP 06/08/202 | 14171W111 | 986 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
CARIBOU BIOSCIENCES INC | COM ADDED | 142038108 | 1,790 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 12,601 | 754,545 | SH | SOLE | 754,545 | 0 | 0 | ||
CORVUS PHARMACEUTICALS INC | COM | 221015100 | 10,072 | 2,081,077 | SH | SOLE | 2,081,077 | 0 | 0 | ||
CYCLERION THERAPEUTICS INC | COM | 23255M105 | 4,931 | 1,606,276 | SH | SOLE | 1,606,276 | 0 | 0 | ||
DESIGN THERAPEUTICS INC | COM | 25056L103 | 27,369 | 1,863,098 | SH | SOLE | 1,863,098 | 0 | 0 | ||
DICERNA PHARMACEUTICALS INC | COM | 253031108 | 25,196 | 1,249,812 | SH | SOLE | 1,249,812 | 0 | 0 | ||
DYNE THERAPEUTICS INC | COM | 26818M108 | 3,569 | 215,000 | SH | SOLE | 215,000 | 0 | 0 | ||
EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 21,234 | 1,279,175 | SH | SOLE | 1,279,175 | 0 | 0 | ||
ERASCA INC | COM ADDED | 29479A108 | 14,854 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
EUCRATES BIOMEDICAL ACQU COR | SHS | G3141W106 | 1,956 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
EUCRATES BIOMEDICAL ACQU COR | *W EXP 10/23/202 | G3141W122 | 652 | 66,666 | SH | SOLE | 66,666 | 0 | 0 | ||
FORMA THERAPEUTICS HLDGS INC | SHS | 34633R104 | 2,090 | 90,141 | SH | SOLE | 90,141 | 0 | 0 | ||
FRAZIER LIFESCIENCES ACQU CO | *W EXP 11/30/202 | G3710A113 | 655 | 66,665 | SH | SOLE | 66,665 | 0 | 0 | ||
FRAZIER LIFESCIENCES ACQU CO | SHS | G3710A105 | 5,770 | 587,615 | SH | SOLE | 587,615 | 0 | 0 | ||
FS DEVELOPMENT CORP II | COM CL A | 30318F100 | 3,692 | 371,014 | SH | SOLE | 371,014 | 0 | 0 | ||
GALAPAGOS NV | SPON ADR | 36315X101 | 82,006 | 1,558,749 | SH | SOLE | 1,558,749 | 0 | 0 | ||
GRITSTONE BIO INC | COM | 39868T105 | 60,056 | 5,560,748 | SH | SOLE | 5,560,748 | 0 | 0 | ||
HEALTH SCIENCES ACQ CORP 2 ORD | SHS | G4411D109 | 3,956 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
HELIX ACQUISITION CORP | COM CL A | G4444C102 | 1,990 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
IGM BIOSCIENCES INC | COM | 449585108 | 2,501 | 38,030 | SH | SOLE | 38,030 | 0 | 0 | ||
IMMUNOVANT INC | COM | 45258J102 | 9,914 | 1,140,819 | SH | SOLE | 1,140,819 | 0 | 0 | ||
ITEOS THERAPEUTICS INC | COM | 46565G104 | 35,185 | 1,303,157 | SH | SOLE | 1,303,157 | 0 | 0 | ||
JANUX THERAPEUTICS INC | COM | 47103J105 | 30,541 | 1,411,975 | SH | SOLE | 1,411,975 | 0 | 0 | ||
JIYA ACQUISITION CORP | COM CL A | 47760M102 | 4,875 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
KINNATE BIOPHARMA INC | COM | 49705R105 | 4,029 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
KRONOS BIO INC | COM | 50107A104 | 8,119 | 387,357 | SH | SOLE | 387,357 | 0 | 0 | ||
KURA ONCOLOGY INC | COM | 50127T109 | 69,759 | 3,724,437 | SH | SOLE | 3,724,437 | 0 | 0 | ||
MEIRAGTX HLDGS PLC | COM | G59665102 | 1,250 | 94,819 | SH | SOLE | 94,819 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | 82,139 | 464,298 | SH | SOLE | 464,298 | 0 | 0 | ||
MORPHIC HLDG INC | COM | 61775R105 | 223,817 | 3,951,566 | SH | SOLE | 3,951,566 | 0 | 0 | ||
NEOLEUKIN THERAPEUTICS INC | COM | 64049K104 | 6,222 | 860,619 | SH | SOLE | 860,619 | 0 | 0 | ||
NGM BIOPHARMACEUTICALS INC | COM | 62921N105 | 5,000 | 245,000 | SH | Call | SOLE | 245,000 | 0 | 0 | |
NURIX THERAPEUTICS INC | COM | 67080M103 | 33,754 | 1,126,640 | SH | SOLE | 1,126,640 | 0 | 0 | ||
NUVATION BIO INC | COM CL A | 67080N101 | 136,292 | 13,711,517 | SH | SOLE | 13,711,517 | 0 | 0 | ||
NUVATION BIO INC | *W EXP 07/07/202 | 67080N119 | 9,576 | 963,333 | SH | SOLE | 963,333 | 0 | 0 | ||
ODONATE THERAPEUTICS INC | COM | 676079106 | 10,846 | 3,727,261 | SH | SOLE | 3,727,261 | 0 | 0 | ||
OMEGA ALPHA SPAC | CL A | G6749V107 | 487 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
ORIC PHARMACEUTICALS INC | COM | 68622P109 | 72,536 | 3,468,944 | SH | SOLE | 3,468,944 | 0 | 0 | ||
OVID THERAPEUTICS INC | COM | 690469101 | 20,436 | 6,082,200 | SH | SOLE | 6,082,200 | 0 | 0 | ||
PMV PHARMACEUTICALS INC | COM | 69353Y103 | 1,490 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | 25,584 | 1,443,800 | SH | SOLE | 1,443,800 | 0 | 0 | ||
PROTHENA CORP PLC | SHS | G72800108 | 803,779 | 11,284,280 | SH | SOLE | 11,284,280 | 0 | 0 | ||
RELAY THERAPEUTICS INC | COM | 75943R102 | 43,678 | 1,385,276 | SH | SOLE | 1,385,276 | 0 | 0 | ||
REPARE THERAPEUTICS INC | COM | 760273102 | 1,286 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
SCHOLAR ROCK HLDG CORP | COM | 80706P103 | 271 | 8,208 | SH | SOLE | 8,208 | 0 | 0 | ||
SHATTUCK LABS INC | COM | 82024L103 | 75,591 | 3,709,072 | SH | SOLE | 3,709,072 | 0 | 0 | ||
SILVERBACK THERAPEUTICS INC | COM | 82835W108 | 11,823 | 1,184,710 | SH | SOLE | 1,184,710 | 0 | 0 | ||
SOLID BIOSCIENCES INC | COM | 83422E105 | 21,994 | 9,202,702 | SH | SOLE | 9,202,702 | 0 | 0 | ||
SURROZEN INC | *W EXP 10/28/2025 | 86889P117 | 471 | 66,665 | SH | SOLE | 66,665 | 0 | 0 | ||
TANGO THERAPEUTICS INC | COM ADDED | 87583X109 | 16,809 | 1,300,000 | SH | SOLE | 1,300,000 | 0 | 0 | ||
TURMERIC ACQUISITION CORP | CL A | G9127T108 | 979 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
TURMERIC ACQUISITION CORP | *W EXP 10/08/202 | G9127T124 | 326 | 33,333 | SH | SOLE | 33,333 | 0 | 0 | ||
VERVE THERAPEUTICS INC | COM | 92539P101 | 4,700 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
VOYAGER THERAPEUTICS INC | COM | 92915B106 | 1,173 | 445,992 | SH | SOLE | 445,992 | 0 | 0 | ||
XENCOR INC | COM | 98401F105 | 160,233 | 4,906,106 | SH | SOLE | 4,906,106 | 0 | 0 |